质子抑制剂调节食道上皮质屏障功能,并与乙氨基基酸细胞交叉交流
Ravi Gautam1, Megha Lal1, Margaret C Carroll1
1Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
概括
像奥梅普拉这样的质子抑制剂通过恢复食道屏障功能和减少炎症来改善美性食道炎 (EoE). 这项研究表明,奥梅普拉可以减轻IL-13对上皮细胞和乙酸细胞的影响,这是EoE病原体的关键.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 生性食道炎 (EoE) 是一种由2型炎症驱动的慢性过敏性疾病.
- 这种EoE涉及到eosinophilic透和食道上皮质异常,包括屏障功能障碍.
- 质子抑制剂 (PPI) 治疗EoE,但其机制尚未完全理解.
研究的目的:
- 调查奥梅普拉对食道上皮质屏障完整性和炎症的影响.
- 阐明 PPI 调节 EoE 2 型炎症的机制.
主要方法:
- 使用了用IL-13和梅治疗的食道上皮细胞的空气-液体接口 (ALI) 培养物.
- 通过穿透测试评估了上皮细胞的化学分泌和埃索诺菲尔的迁移.
- 利用上皮细胞和乙素的共同培养系统来评估粘附和激活标记物.
主要成果:
- 奥梅普拉恢复了IL-13治疗的ALI培养物和改变基因表达的屏障完整性.
- 奥梅普拉降低了STAT6酸化,并上调了德斯莫格林-1.
- 奥梅普拉降低了关键化学因子 (Eotaxin-3,CXCL10) 的调节,并降低了埃索因菲尔粘附和激活标志物.
结论:
- 在上皮细胞和共同培养模型中,奥梅普拉有效抵消了IL-13诱导的影响.
- 奥梅普拉缓解了与EoE相关的屏障功能障碍和化学激素表达.
- 奥美普拉减少了乙氨基基细胞的粘附和激活,这表明它在EoE中发挥了治疗作用.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.0K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.0K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.4K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.1K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.3K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.3K
Mucosal Barrier of the Stomach
2.6K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.6K


